Asciminib Add-on to Imatinib Demonstrates Sustained High Rates of Ongoing Therapy and Deep Molecular Responses with Prolonged Follow-Up in the ASC4MORE Study

Journal of Hematology & Oncology（2024）

引用 0|浏览0

关键词

ASC4MORE,CML,Asciminib,Tyrosine kinase inhibitors,Deep molecular response,Imatinib,Add-on,Combination

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要